Post Hoc Analysis Showed CIMZIA® (Certolizumab Pegol) Resulted in Meaningful Efficacy for RA Patients with High Levels of Rheumatoid Factor (RF) ...Middle East

A post hoc analysis from the EXXELERATE Phase 4 trial showed that 65.7 percent of CIMZIA-treated patients with rheumatoid arthritis (RA) and high rheumatoid factor (RF) levels achieved low disease activity at Week 1041 CIMZIA maintained drug concentrations and achieved Low Disease...

Hence then, the article about post hoc analysis showed cimzia certolizumab pegol resulted in meaningful efficacy for ra patients with high levels of rheumatoid factor rf was published today ( Saturday 11/11/2023 - 03:16 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Post Hoc Analysis Showed CIMZIA® (Certolizumab Pegol) Resulted in Meaningful Efficacy for RA Patients with High Levels of Rheumatoid Factor (RF) )

Also on site :

• We Asked 3 Oncologists About the Worst Thing You Can Do for Cancer Risk and They All Said the Same Thing
• Officer accuses disabled driver of holding phone with missing hand
• Box Office: ‘Backrooms’ Scares Up $38 Million on Friday, Already Shattering Record for A24’s Best Opening Weekend